Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome-Reference-Cited by-同舟云学术

Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome

Published:2016-05-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Islam Md. Asiful¹,Alam Fahmida¹,Sasongko Teguh H¹,Husin Azlan²,Abdullah Sarimah³,Gan Siew Hua¹,Wong Kah Keng⁴

Affiliation:

1. Universiti Sains Malaysia; Human Genome Centre, School of Medical Sciences, Health Campus; Jalan Raja Perempuan Zainab II, Kubang Kerian Kota Bharu Kelantan Malaysia 16150

2. Universiti Sains Malaysia; Department of Internal Medicine, School of Medical Sciences, Health Campus; Jalan Raja Perempuan Zainab II, Kubang Kerian Kota Bharu Malaysia

3. Universiti Sains Malaysia; Unit of Biostatistics and Research Methodology; Jalan Raja Perempuan Zainab II, Kubang Kerian Kota Bharu Kelantan Malaysia 16150

4. Universiti Sains Malaysia; Department of Immunology, School of Medical Sciences, Health Campus; 16150 Kubang Kerian Kota Bharu Malaysia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference106 articles.

1. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients;Alarcón-Segovia;Medicine,1989

2. Organ damage and quality of life in Antiphospholipid Syndrome;Alba;Current Rheumatology Reports,2016

3. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition);Ansell;Chest,2008

4. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I;Arnout;Thrombosis and Haemostasis,1999

5. The "primary" antiphospholipid syndrome: major clinical and serological features;Asherson;Medicine,1989

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome;Cochrane Database of Systematic Reviews;2020-10-12

2. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies;Cochrane Database of Systematic Reviews;2018-07-13

3. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome;Cochrane Database of Systematic Reviews;2017-10-02

4. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies;Cochrane Database of Systematic Reviews;2017-02-02